- Home
- UMAC vs SLS Comparison
UMAC vs SLS Comparison
Compare UMAC & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMAC
- SLS
- Stock Information
- Founded
- UMAC 2019
- SLS 2012
- Country
- UMAC United States
- SLS United States
- Employees
- UMAC N/A
- SLS N/A
- Industry
- UMAC
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- UMAC
- SLS Health Care
- Exchange
- UMAC Nasdaq
- SLS Nasdaq
- Market Cap
- UMAC 93.3M
- SLS 89.6M
- IPO Year
- UMAC 2024
- SLS N/A
- Fundamental
- Price
- UMAC $6.15
- SLS $1.09
- Analyst Decision
- UMAC Strong Buy
- SLS
- Analyst Count
- UMAC 3
- SLS 0
- Target Price
- UMAC $14.00
- SLS N/A
- AVG Volume (30 Days)
- UMAC 783.6K
- SLS 815.8K
- Earning Date
- UMAC 03-27-2025
- SLS 03-20-2025
- Dividend Yield
- UMAC N/A
- SLS N/A
- EPS Growth
- UMAC N/A
- SLS N/A
- EPS
- UMAC N/A
- SLS N/A
- Revenue
- UMAC $5,565,319.00
- SLS N/A
- Revenue This Year
- UMAC N/A
- SLS N/A
- Revenue Next Year
- UMAC $80.62
- SLS N/A
- P/E Ratio
- UMAC N/A
- SLS N/A
- Revenue Growth
- UMAC N/A
- SLS N/A
- 52 Week Low
- UMAC $0.98
- SLS $0.77
- 52 Week High
- UMAC $23.62
- SLS $1.84
- Technical
- Relative Strength Index (RSI)
- UMAC 39.59
- SLS 40.56
- Support Level
- UMAC $6.60
- SLS $1.13
- Resistance Level
- UMAC $7.35
- SLS $1.25
- Average True Range (ATR)
- UMAC 0.72
- SLS 0.07
- MACD
- UMAC 0.13
- SLS -0.01
- Stochastic Oscillator
- UMAC 23.11
- SLS 17.39
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is a development stage technology company.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.